RECRUITING

Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To determine the impact of unrestricted postoperative activity on intermediate- and long-term continence outcomes of mid-urethral sling surgery in women with stress urinary incontinence. To assess the natural return to baseline activity level when patients are unrestricted following mid-urethral sling surgery with or without concomitant anterior or posterior pelvic organ prolapse repair.

Official Title

IMpact of Unrestricted ACTIVity Following Mid-Urethral Sling Surgery (I'M ACTIVe): Quality of Life and Cost Implications

Quick Facts

Study Start:2011-12
Study Completion:2031-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02316275

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Non-pregnant female
  2. * Self-reported stress urinary incontinence
  3. * Incontinence demonstrated on physical exam and/or by an urodynamics study
  4. * Planned mid-urethral sling surgery
  5. * Available for 2 years of follow-up
  6. * Willing and able to complete study assessments per the judgment of the treating clinician
  7. * Willing and able to provide written informed consent
  1. * Age \<18 years at time of enrollment
  2. * Concomitant prolapse surgery other than anterior colporrhaphy
  3. * Currently pregnant or \<12 months post-partum
  4. * Unable to read, write, or comprehend English

Contacts and Locations

Study Contact

Jennifer Anger, MD, MPH
CONTACT
3103852992

Principal Investigator

Jennifer Anger, MD, MPH
PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center

Study Locations (Sites)

Cedars-Sinai Medical Center
Beverly Hills, California, 90211
United States

Collaborators and Investigators

Sponsor: Cedars-Sinai Medical Center

  • Jennifer Anger, MD, MPH, PRINCIPAL_INVESTIGATOR, Cedars-Sinai Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2011-12
Study Completion Date2031-12

Study Record Updates

Study Start Date2011-12
Study Completion Date2031-12

Terms related to this study

Additional Relevant MeSH Terms

  • Stress Urinary Incontinence